DIAGNOSIS AND TREATMENT OF INCIDENTAL PROSTATE CANCER


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Incidental prostate cancer (IPC) - cancer, identified by morphological evaluation of prostate tissue removed during transurethral resection (TUR) or open prostatectomy, in cases where the results of preoperative prostate biopsy revealed no prostate cancer. Literature review presents the data on the incidence of IPC, features of its diagnosis, prediction of tumor progression, and choice of treatment approaches. Many questions remain unresolved and require additional research.

Full Text

Restricted Access

About the authors

L. V Marisov

SRI of Uronephrology and Reproductive Human Health, SBEI HPE First MSMU n.a. I.M. Sechenov

Email: marisov51@maiI.ru
Postgraduate Student

A. Z Vinarov

SRI of Uronephrology and Reproductive Human Health, SBEI HPE First MSMU n.a. I.M. Sechenov

References

  1. Лопаткин Н.А. Урология Национальное руководство. М.: «ГЭОТАР Медиа», 2009, 1024 с.
  2. Klotz L. Active surveillance for prostate cancer: trials and tribulations. World J Urol. 2008;26(5):437-442.
  3. Jones J.S., Follis H.W., Johnson J.R. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Prostate Сancer Prostatic Dis. 2009;12(1):57-60.
  4. Argyropoulos A., Doumas K., Farmakis A. et al. Characteristics of patients with stage T1b incidental prostate cancer. Scand J Urol Nephrol. 2005;39(4):289-293.
  5. Antunes A.A., Freire Gde C., Aiello Filho D. et al. Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics 2006;61(6):545-550.
  6. van Andel G., Vleeming R., Kurth K., de Reijke T.M. Incidental carcinoma of the prostate. Semin Surg Oncol 1995;11(1):36-45.
  7. Tombal B., De Visccher L., Cosyns J.P. et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999;84(9):1015-1020.
  8. Meguro N., Maeda O., Saiki S. et al. Clinical significance of prostate specific antigen (PSA) and PSA density in the detection of T1a and T1b prostate cancer. Hinyokika Kiyo 1998;44(9):639-643.
  9. Vecchioli Scaldazza C. Incidental carcinoma of the prostate. Study of 683 patients operated upon for benign prostatic hypertrophy. Minerva Urol Nefrol 1992;44(2):109-12.
  10. Zigeuner R.E., Lipsky K., Riedler I. et al. Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 2003;62(3):451-455.
  11. Kanno H., Umemoto S., Izumi K. et al. Prostate cancer development after transurethral resection of the prostate histopathological studies of radical prostatectomy specimens. Nippon Hinyokika Gakkai Zasshi 2006;97(4):649-659.
  12. Picurelli Oltra L., Sendra Torres A., Fernandez Rodriguez A. et al. Incidental prostatic adenocarcinoma in the ere of the PSA. Actas Urol Esp 1997;21(4):354-356.
  13. Marmiroli R., Antunes A.A. et al. Standard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: analysis of 100 cases from a high-volume urologic center. Clinics (Sao Paulo). 2012;67(12):1415-1418.
  14. Yoo CZhao Z., Ma W., Zeng G., Qi D. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia. Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital, Guangzhou Medical College, Guangzhou, Guangdong Province, China. zgzhaodr@yahoo. com.cn
  15. Voigt S., Hüttig F. et al. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benignprostate hyperplasia? Prostate. 2011;71(12):1325-1331.
  16. Глыбочко П.В., Понукалин А.Н. и др. Прогностические факторы у больных инцидентальным раком предстательной железы. Онкоурология. 2008;1:41-44.
  17. Pelzer A.E., Bektic J., Berger A.P. et al. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project. Eur. Urol. 2005;48(6):916-921.
  18. Hayakawa T., Kanemitsu N., Mitsuya H. et al. Systematic prostate biopsy before transurethral resection of the prostate. 2004;95(3):588-595.
  19. Escudero Bregante J.F., Lôpez Cubillana P. et al. Clinical efficacy of prostatic biopsy. Experience in our center from 1990 to 2002. Actas Urol Esp. 2008;32(7):713-716.
  20. Lipsky K., Riedler I. et al. Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. http://www.ncbi.nlm.nih.gov/pubmed?term=Zigeuner%20RE%5BAut hor%5D&cauthor=true&cauthor_uid=12946745. Urology. 2003;62(3): 451-455.
  21. Herranz Amo F., Diez Cordero J.M. et al. Incidental prostatic cancer. Actas Urol Esp. 1999;23(10):848-652.
  22. Helfand B.T., Anderson C.B. et al. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for вenign prostatic hyperplasia. Urology. 2009;74 (1):177-183.
  23. Dellavedova T., Ponzano R. et al. Prostate cancer as incidental finding in transurethral resection. Arch Esp Urol. 2010;63(10):855-861.
  24. Froehner M., Buck L.M., Koch R. et al. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer. BJU Int. 2009 ;104(1):25-28.
  25. Andrèn O., Garmo H., Mucci L. et al. Incidence and mortality of incidental prostate cancer: a Swedish register-based study. Br J Cancer. 2009;100(1):170-173.
  26. Allue Lopez M., Allepuz Losa C., Borque Fernando A. et al. Incidental prostatic cancer: T1a-T1b. Our experience after observation/radical surgery and literature review. Actas Urol Esp. 2006;30(8):749-753.
  27. Capitanio U., Scattoni V., Freschi M. et al. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur. Urol. 2008;54(1):118-125.
  28. Heidenreich A., Bastian P.J., Bellmunt J. et al. Guidelines on Prostate Cancer. EAU Guidelines 2012.
  29. Masue N., Deguchi T., Nakano M. et al. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b. Int J Urol. 2005;12(12):1045-1049.
  30. Ahmad S., O'Kelly F. Survival after incidental prostate cancer diagnosis at transurethral resection of prostate: 10-year outcomes. Ir J Med Sci. 2012;181(1):27-31.
  31. Chodak G.W., Thisted R.A. et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330(4):242-248.
  32. Lowe B.A. Management of stage T1a Prostate cancer. Semin Urol Oncol. 1996;14(3):178-82.
  33. Loughlin K.R., Renshaw A.A., Kumar S. Expectant management of stage A-1 (T1a) prostate cancer utilizing serum PSA levels: a preliminary report. J Surg Oncol. 1999;70(1):49-53.
  34. Morân Pascual E., Dicapua Sacoto C., Trassierra Villa M. Watchful waiting in incidental adenocarcinoma of the prostate.Actas Urol Esp. 2010;34(10):854-859.
  35. Capitanio U. Contemporary management of patients with T1a and T1b prostate cancer. Curr. Opin. Urol. 2011;21(3):252-256.
  36. Morita M., Matsuura T. Successful Treatment of Incidental Prostate Cancer by Radical Transurethral Resection of Prostate Cancer. Clin Genitourin Cancer. 2012 Nov 5. pii: S1558-7673(12)00212-1. doi: 10.1016/j.clgc.2012.09.012.
  37. Шосси К. Мировой опыт HIFU-терапии РПЖ Экспериментальная и клиническая урология. 2011;2-3:44-47.
  38. Ramon J., Rossignol G., Leandri P. et al. Morbidity of radical retropubic prostatectomy following previous prostate resection. J Surg Oncol. 1994;55:14-19.
  39. Colombo R., Naspro R., Salonia A. et al. Radical prostatectomy after previous prostate surgery. Clinical and functional outcomes. J Urol 2006; 176: 2459-2463.
  40. Palisaar J.R., Wenske S. et al. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate. BJU International. 2009;104(5):611-615.
  41. Jaffe J., Stakhovsky O., Cathelineau X et al. Surgical outcomes for men undergoing laparoscopic radical prostatectomy after transurethral resection of the prostate. J Urol. 2007;178(2):483-487.
  42. Changhee Yoo, Cheol Young Oh et al. Preoperative Clinical Factors for Diagnosis of Incidental Prostate Cancer in the Era of Tissue-Ablative Surgery for Benign Prostatic Hyperplasia: A Korean Multi-Center Review. Korean J Urol 2012;53:391-395.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies